Skip to content

Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07069478
Enrollment
125
Registered
2025-07-16
Start date
2025-06-16
Completion date
2028-12-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stress Reaction, Cannabidiol, CBD, Stress

Keywords

cardiovascular reactivity, , , ,, hypothalamic-pituitary-adrenal axis, stress, mood, CBD use

Brief summary

The aim of this study is to determine the effects of regular cannabidiol (CBD) use on the psychobiological mechanisms of the stress response. This will be achieved by comparing acute stress responses of adults who either use or do not use CBD regularly. Correlates of CBD use, including tobacco use, will be collected.

Interventions

Experimental Stress: Behavioral induction of acute psychosocial and physiological stress. First, participants will be provided with a speech topic and given 4 minutes to prepare a speech that they subsequently deliver in front of evaluators and a video recorder. Then, participants will complete a mental arithmetic task in front of the evaluators for 8 minutes. Then, participants will complete a cold pressor task in which they submerge their hand in ice water for 90 seconds.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Single group assignment; all participants experience baseline rest, acute stress tasks, and recovery rest.

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults who are relatively healthy and aged 21-70 years. * Must keep a normal sleep schedule (sleep during nighttime, awake during daytime). * Must either (1) use CBD daily/regularly or (2) not use CBD regularly.

Exclusion criteria

* Participated in previous acute stress studies that included a similar stress induction. * Current, unstable: major psychiatric disorder or medical condition (e.g., uncontrolled hypertension above 160/100). * Self-reported current pregnancy. * Self-reported current use of illicit substances (other than cannabis). * Non-compliance with instructions for study visit (abstinence from alcohol, caffeine, physical activity, etc.) * Students of the principal researcher

Design outcomes

Primary

MeasureTime frameDescription
Change in subjective states (stress, anxiety, positive affect)2.5 hoursParticipants will self-report the extent to which they have felt stressed, overwhelmed, anxious/nervous, cheerful, and happy during the last 30 minutes before acute stress, immediately after acute stress, and after a recovery period. The Subjective States Questionnaire will be used to score responses. The minimum values are 0 (not at all) and the maximum values are 7 (very strongly). Higher scores mean more stress, more anxiety, and more positive affect.
Change in cardiovascular activity and cortisol2.5 hoursSaliva will be collected (for later cortisol assays) and cardiovascular activity will be measured before, during, and after acute stress.

Countries

United States

Contacts

CONTACTStress and Resilience Research Labs
umdbml@d.umn.edu2187268623
PRINCIPAL_INVESTIGATORMustafa al'Absi

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026